Results 11 to 20 of about 5,469,873 (362)
Heart failure [PDF]
Nursing Standard, 2014 Essential facts Heart failure affects about 900,000 people in the UK. The condition can affect people of all ages, but it is more common in older people, with more than half of all patients over the age of 75. It is caused by the heart failing to pump enough blood around the body at the right pressure, usually because the heart muscle has become too ...Yanggan Wang, Yanzong Yang, Xun Aiopenaire +5 more sourcesSemaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
New England Journal of Medicine, 2023 BACKGROUND
Heart failure with preserved ejection fraction is increasing in prevalence and is associated with a high symptom burden and functional impairment, especially in persons with obesity.M. Kosiborod, S. Z. Abildstrom, B. Borlaug, J. Butler, S. Rasmussen, M. Davies, G. Hovingh, D. Kitzman, M. Lindegaard, D. Møller, Sanjiv J. Shah, M. Treppendahl, S. Verma, W. Abhayaratna, F. Ahmed, V. Chopra, J. Ezekowitz, Michael Fu, Hiroshi Ito, M. Lelonek, V. Melenovský, B. Merkely, Julio Núñez, E. Perna, M. Schou, M. Senni, K. Sharma, P. van der Meer, Dirk von Lewinski, Dennis Wolf, M. Petrie +30 moresemanticscholar +1 more sourceThe International Classification of Functioning, Disabilities, and Health categories rated as necessary for care planning for older patients with heart failure: a survey of care managers in Japan
BMC Geriatrics, 2021 Background Establishing an information-sharing system between medical professionals and welfare/care professionals may help prevent heart failure (HF) exacerbations in community-dwelling older adults.Shigehito Shiota, Toshiro Kitagawa, Takayuki Hidaka, Naoya Goto, Naoki Mio, Kana Kanai, Makiko Naka, Hiroko Togino, Mariko Mochizuki, Hiroyuki Ochikubo, Yukiko Nakano, Yasuki Kihara, Hiroaki Kimura +12 moredoaj +1 more sourceUniversal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
European Journal of Heart Failure, 2021 In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or ...B. Bozkurt, A. Coats, H. Tsutsui, Ca Magdy Abdelhamid, S. Adamopoulos, N. Albert, S. Anker, J. Atherton, M. Böhm, J. Butler, M. Drazner, G. Michael Felker, G. Filippatos, M. Fiuzat, G. Fonarow, J. Gómez-Mesa, P. Heidenreich, T. Imamura, E. Jankowska, J. Januzzi, P. Khazanie, K. Kinugawa, C. Lam, Y. Matsue, M. Metra, T. Ohtani, Massimo Francesco Piepoli, P. Ponikowski, G. Rosano, Y. Sakata, P. Seferovic, R. Starling, J. Teerlink, O. Vardeny, Kazuhiro Yamamoto, C. Yancy, Jian Zhang, S. Zieroth +37 moresemanticscholar +1 more sourceBurden, Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2023 Background Heart failure is a public health issue worldwide. However, no comprehensive study on the global burden of heart failure and its contributing causes has been reported.Tao Yan, Shijie Zhu, Xiujie Yin, Changming Xie, Junqiang Xue, Miao Zhu, Fan Weng, Shichao Zhu, Bitao Xiang, X. Zhou, Gang Liu, Yang Ming, K. Zhu, Chunsheng Wang, Changfa Guo +14 moresemanticscholar +1 more sourceBeta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
Medical Sciences, 2019 Clinical trials have shown the benefits of β-blockers therapy in patients with heart failure reduced ejection fraction. These benefits include improved survival and a reduced need for hospitalization. Cardiac resynchronization therapy has emerged as Daniele Masarone, Marina Verrengia, Ernesto Ammendola, Rita Gravino, Fabio Valente, Rossella Vastarella, Marta Rubino, Giuseppe Limongelli, Giuseppe Pacileo +8 moredoaj +1 more sourceDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
New England Journal of Medicine, 2019 BACKGROUND
In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the effects of J. McMurray, S. Solomon, S. Inzucchi, L. Køber, M. Kosiborod, F. Martinez, P. Ponikowski, M. Sabatine, I. Anand, J. Bělohlávek, M. Böhm, C. Chiang, V. Chopra, Rudolf A. de Boer, Akshay S. Desai, M. Diez, J. Drożdż, A. Dukát, J. Ge, J. Howlett, T. Katova, M. Kitakaze, C. Ljungman, B. Merkely, J. Nicolau, E. O’Meara, M. Petrie, P. N. Vinh, M. Schou, S. Tereshchenko, S. Verma, C. Held, D. DeMets, K. Docherty, P. Jhund, O. Bengtsson, M. Sjöstrand, A. Langkilde, Modele O Ogunniyi +38 moresemanticscholar +1 more sourcePractical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC
European Journal of Heart Failure, 2023 Diagnosing heart failure is often difficult due to the non‐specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure.Antoni Bayés-Genís, Kieran F Doherty, Mark C. Petrie, J. Januzzi, C. Mueller, Lisa Andreson, B. Bozkurt, J. Butler, O. Chioncel, J. Cleland, R. Christodorescu, Stefano Del Prato, F. Gustafsson, Carolyn S. P. Lam, B. Moura, R. Pop-Busui, Petar M Seferović, M. Volterrani, M. Vaduganathan, M. Metra, Giuseppe M C Rosano +20 moresemanticscholar +1 more source2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation, 2022 AIM
The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart ...P. Heidenreich, B. Bozkurt, D. Aguilar, L. Allen, Joni J. Byun, Monica Colvin, A. Deswal, M. Drazner, S. Dunlay, Linda R. Evers, J. Fang, S. Fedson, G. Fonarow, S. Hayek, Adrian F. Hernandez, P. Khazanie, M. Kittleson, Christopher S. Lee, M. Link, C. Milano, Lorraine C. Nnacheta, Alexander T. Sandhu, L. Stevenson, O. Vardeny, A. Vest, C. Yancy +25 moresemanticscholar +1 more source